U.S. Stock Funds
U.S. stock markets have performed very well in 2013. Looking into indices such as S&P 500, Dow, or NASDAQ; you will notice YTD returns of 25%-40%. Investing in individual stocks has been challenging as well. Using investment fund such as closed end fund can minimize your risk and increase your return. The following is the top performing U.S. stock closed end funds in 2013.From the list you may find variety of fund’s sectors. Most of the top performer sectors include Health/Biotech sector, general equity, tax managed equity, finance, energy MLP, etc. Find whether these top funds are suitable for your 2014 investment plan in your brokerage or retirement accounts. Check the fund review and performance below.
The 10 top performing US stock closed end funds 2013 are:
- H&Q Healthcare Investors
- Gabelli Equity Trust
- H&Q Life Sciences Investors
- Liberty All-Star Growth
- Royce Micro Cap Trust
- Gabelli Dividend & Income
- Kayne Anderson MLP
- Nuveen Tax-Adv Total Return
- JH Financial Opportunities
- Nuveen Core Equity Alpha
H&Q Healthcare Investors Fund (HQH)
U.S. stock has performed well in 2013. Some stocks even achieve a higher return than indices such as DOW or S&P 500. In 2013, the best performing U.S. stock closed end fund is H&Q Healthcare Investors Fund. This stock fund managed to return 69.88%. This CEF fund invests mainly in healthcare and medical technology firms, private equity and foreign securities. The fund’s manager is Daniel R. Omstead.This top equity closed end fund has a 3 year average return of 37.28%. The top 3 stocks in its assets are Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, and Celgene Corporation.
Gabelli Equity Trust Fund (GAB)
Gabelli Equity Trust Fund is seeking to provide long term capital growth with income. It utilizes its assets to purchase equity securities. This stock fund has an expense ratio of 1.47%. This equity fund has a high yield of 10.30%. It is managed by Mario J Gabelli and Zahid Siddique.Morningstar has ranked this top performing US stock closed end fund with 5 stars and bronze rating. The fund has returned 22.61% over the past 3 year, and 30.14% over the past 5 year. In 2013, it has a year to date return of 56.47%.
The top 3 country allocations are North America region (81%), European developed (14%), and Latin America region (2.44%). The top 5 stocks are Rollins Inc, American Express Co, Honeywell International Inc, Swedish Match AB, and Deere & Co.
Liberty All-Star Growth Fund (ASG)
In 2013, Liberty All-Star Growth Fund has high YTD return of 52.71%. This equity fund invests most of its assets in small, mid and large cap growth equity securities. This fund has total net assets of $137 million. The expense ratio is 1.46%. The fund’s sponsor is ALPS Advisors, Inc.For the past 5 years, the fund’s performance is as follows:
- Year 2012: 13.93%
- Year 2011: -4.31%
- Year 2010: 35.48%
- Year 2009: 40.38%
Fund Performance
| No | Fund Name | Ticker | Type | Nav Price | Yield | Premium/ Discount | YTD Return |
|---|---|---|---|---|---|---|---|
| 1 | H&Q Healthcare Investors | HQH | Health/Biotech | $26.17 | 7.34% | 4.17% | 69.88% |
| 2 | Gabelli Equity Trust | GAB | General Equity | $7.15 | 10.06% | 11.19% | 56.47% |
| 3 | H&Q Life Sciences Investors | HQL | Health/Biotech | $21.07 | 7.64% | -0.62% | 55.92% |
| 4 | Liberty All-Star Growth | ASG | General Equity | $5.88 | 6.21% | -1.36% | 52.71% |
| 5 | Royce Micro Cap Trust | RMT | General Equity | $14.08 | 30.72% | -10.30% | 50.38% |
| 6 | Gabelli Dividend & Income | GDV | Equity Tax-Advantaged | $24.07 | 4.86% | -7.69% | 44.92% |
| 7 | Kayne Anderson MLP | KYN | Energy MLP | $34.36 | 5.90% | 15.92% | 42.43% |
| 8 | Nuveen Tax-Adv Total Return | JTA | Equity Tax-Advantaged | $14.63 | 6.93% | -5.26% | 42.05% |
| 9 | JH Financial Opportunities | BTO | Finance | $24.56 | 5.04% | -4.23% | 41.19% |
| 10 | Nuveen Core Equity Alpha | JCE | General Equity | $17.83 | 6.59% | -4.71% | 39.21% |
| 11 | Royce Value Trust | RVT | General Equity | $18.11 | 5.21% | -11.04% | 37.83% |
| 12 | BlackRock Health Sciences | BME | Health/Biotech | $34.18 | 4.99% | 0.94% | 36.62% |
| 13 | EV Enhanced Equity Income II | EOS | Covered Call | $14.08 | 8.06% | -7.46% | 36.49% |
| 14 | Source Capital Inc | SOR | General Equity | $73.89 | 4.45% | -8.85% | 35.39% |
| 15 | EV Tax Adv Global Dividend Inc | ETG | Equity Tax-Advantaged | $17.97 | 7.22% | -5.23% | 34.62% |
| 16 | Gabelli Glb Health & Wellness | GRX | Health/Biotech | $11.29 | 3.77% | -6.11% | 34.46% |
| 17 | EV Enhanced Equity Income | EOI | Covered Call | $14.42 | 7.90% | -9.02% | 34.18% |
| 18 | General American Investors | GAM | General Equity | $40.67 | 0.76% | -13.67% | 33.89% |
| 19 | Liberty All-Star Equity | USA | General Equity | $6.68 | 6.69% | -10.48% | 33.77% |
| 20 | EV Tax Adv Global Div Opps | ETO | Equity Tax-Advantaged | $26.20 | 7.33% | -6.30% | 32.70% |
No comments:
Post a Comment